A Pulmonary Arterial Hypertension Study With Macitentan to Validate the PAH-SYMPACT™ in France, Italy and Spain

Clinical trial NCT02081690 · TERMINATED

Trial details

NCT number: NCT02081690
Sponsor: Actelion
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2014-03-01
Primary completion: 2015-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.